Clever Leaves Reports Fourth Quarter and Full Year 2023 Results
– 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue –
– Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year –
Related news for (CLVRW)
- Clever Leaves Announces Voluntary Delisting and SEC Deregistration
- Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)
- Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)